Literature DB >> 15658034

Direct-to-consumer genetic tests, government oversight, and the First Amendment: what the government can (and can't) do to protect the public's health.

Gail H Javitt1, Erica Stanley, Kathy Hudson.   

Abstract

Keywords:  Federal Trade Commission; First Amendment; Genetics and Reproduction; Health Care and Public Health; Legal Approach

Mesh：

Year:  2004        PMID： 15658034

Source DB:  PubMed          Journal:  Oklahoma Law Rev        ISSN： 0030-1752


× No keyword cloud information.
  10 in total

1.  Which way for genetic-test regulation? Assign regulation appropriate to the level of risk.

Authors:  Gail Javitt
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

2.  Dermatology in the postgenomic era: harnessing human variation for personalized medicine.

Authors:  Anthony E Oro
Journal:  Arch Dermatol       Date:  2008-03

3.  Public awareness and use of direct-to-consumer genetic tests: results from 3 state population-based surveys, 2006.

Authors:  Katrina A B Goddard; Debra Duquette; Amy Zlot; Jenny Johnson; Ann Annis-Emeott; Patrick W Lee; Mary Pat Bland; Karen L Edwards; Kristin Oehlke; Rebecca T Giles; Ann Rafferty; Michelle L Cook; Muin J Khoury
Journal:  Am J Public Health       Date:  2008-12-23       Impact factor: 9.308

4.  Informed Choice in Direct-to-Consumer Genetic Testing for Alzheimer and Other Diseases: Lessons from Two Cases.

Authors:  Donna A Messner
Journal:  New Genet Soc       Date:  2011

5.  Update on Direct-to-Consumer Marketing in Oncology.

Authors:  Stacy W Gray; Gregory A Abel
Journal:  J Oncol Pract       Date:  2012-02-21       Impact factor: 3.840

6.  The impact of risk information exposure on women's beliefs about direct-to-consumer genetic testing for BRCA mutations.

Authors:  S W Gray; R C Hornik; J S Schwartz; K Armstrong
Journal:  Clin Genet       Date:  2011-11-02       Impact factor: 4.438

Review 7.  Genetic susceptibility testing for neurodegenerative diseases: ethical and practice issues.

Authors:  J Scott Roberts; Wendy R Uhlmann
Journal:  Prog Neurobiol       Date:  2013-04-09       Impact factor: 11.685

8.  Risk information exposure and direct-to-consumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer.

Authors:  Stacy W Gray; Cristin O'Grady; Lauren Karp; Daniel Smith; J Sanford Schwartz; Robert C Hornik; Katrina Armstrong
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-24       Impact factor: 4.254

Review 9.  Personal genome testing: test characteristics to clarify the discourse on ethical, legal and societal issues.

Authors:  Eline M Bunnik; Maartje H N Schermer; A Cecile J W Janssens
Journal:  BMC Med Ethics       Date:  2011-06-14       Impact factor: 2.652

Review 10.  Genetic data and electronic health records: a discussion of ethical, logistical and technological considerations.

Authors:  Kimberly Shoenbill; Norman Fost; Umberto Tachinardi; Eneida A Mendonca
Journal:  J Am Med Inform Assoc       Date:  2013-06-14       Impact factor: 4.497
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.